SCR-LIP-000765 · Claim · machine-readable JSON →

Reliance on body mass index and the absence of validated objective criteria or biomarkers are reported to hinder recognition of lipedema.

General proposition consolidated from 5 earlier single-paper claims; each study's own result is shown as its finding.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
low (GRADE)
Evidence
6 source(s) · by Amato
Dates
2026-11-20 → 2026-11-20

Structured evidence, machine-compiled — not a verdict.

Evidence over time

20202026Lipedema—Pathogenesis, Diagnosis, and Treatment Options — Kruppa et al. (2020) · consistentUltrasound criteria for lipedema diagnosis — Amato et al. (2021) · consistentAmato ACM, 2021 · consistentEditorial for “Subcutaneous Adipose Tissue Edema in Lipedema Revealed by Noninvasive 3T Magnetic Resonance Lymphangiography” — Wang (2023) · consistentLipedema: pathophysiological insights and therapeutic strategies — An update for dermatologists (2026) · consistentDor crônica e biomarcadores inflamatórios em mulheres com obesidade: Impacto dos Fenótipos Adiposos e Lipedema — Silva et al. (2026) · consistent

Evidence (6)

Context (PECO)

Populationwomen evaluated for limb fat/obesity
Conditionlipedema
ExposureBMI-only obesity classification
Comparatorfat-distribution-aware assessment
Outcomeunderdiagnosis of lipedema
Scopediagnostic reasoning

Answers these questions

Gaps & caveats

Change log